ATYPICAL FIBROXANTHOMA

Clinical trials for ATYPICAL FIBROXANTHOMA explained in plain language.

Never miss a new study

Get alerted when new ATYPICAL FIBROXANTHOMA trials appear

Sign up with your email to follow new studies for ATYPICAL FIBROXANTHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for young sarcoma patients: trial tests aggressive drug combo

Disease control Recruiting now

This study is testing a combination of chemotherapy drugs (ifosfamide, doxorubicin), a targeted drug (pazopanib), and sometimes a newer drug (selinexor) and radiation therapy for young patients (up to age 30) with rare soft tissue cancers. The goal is to see if this approach can …

Matched conditions: ATYPICAL FIBROXANTHOMA

Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

ATYPICAL FIBROXANTHOMA

Get alerted when new ATYPICAL FIBROXANTHOMA trials appear

New hope for young sarcoma patients: trial tests aggressive drug combo